Lobbying client · LD-2 disclosures
Janssen Pharmaceuticals, Inc. (Cardiovascular Coaliltion)
New Jersey
20 filings from 1 registrant · 2017–2022 · latest filed Jul 20, 2022
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medicare/Medicaid
MMM
20 filings
Health Issues
HCR
16 filings
Veterans
VET
7 filings
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
Who did the lobbying
Every lobbyist named on this client's filings.
- Jason S Mckitrick Liberty Partners Group, LLCCovered position: Analyst, House Budget; LA Rep. John Kasich21 filingsthrough 2022
- Andrew L Woods Liberty Partners Group, LLC21 filingsthrough 2022
- Stacey Smith Liberty Partners Group, LLCCovered position: Legislative Assistant, Senator Bill Nelson (FL)19 filingsthrough 2021
- Eric S Berger Liberty Partners Group, LLCCovered position: Prof. Staffer, House Energy and Commerce CMTE13 filings
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: janssen-pharmaceuticals-inc-cardiovascular-coaliltion.